How the US Food and Drug Administration evaluates the scientific evidence for health claims

Nutrition Reviews
Kathleen C EllwoodClaudine J Kavanaugh

Abstract

Health claims describe the relationship between a substance (food or component of food) and a disease or health-related condition. They were first authorized through the Nutrition Labeling and Education Act of 1990. The standard set by the US Congress for the scientific evidence required to authorize a claim was the significant scientific agreement standard. This strong standard was challenged by several manufacturers of dietary supplements. Several court decisions directed the US Food and Drug Administration (FDA) to provide for dietary supplement claims not meeting the significant scientific agreement standard by adding a disclaimer to the claim that would eliminate the claim's potential to be misleading. In December 2002, the FDA announced a major new initiative, "The Consumer Health Information for Better Nutrition Initiative," which, among other things, provided for the use of qualified health claims for both conventional foods and dietary supplements. The process for reviewing the scientific evidence for a claim reaching significant scientific agreement and for those that require qualifying language is the same. In January 2009, the FDA issued a guidance document entitled "Evidence-Based Review System for the Scientific E...Continue Reading

References

Jun 1, 1991·Journal of Clinical Pharmacology·B Spilker
Jun 5, 1999·The American Journal of Clinical Nutrition·C T SemposN D Ernst
Jul 21, 2005·JAMA : the Journal of the American Medical Association·Alice H Lichtenstein, Robert M Russell
Nov 22, 2008·The Journal of Nutrition·Alice H LichtensteinJoseph Lau

❮ Previous
Next ❯

Citations

Sep 22, 2011·The Proceedings of the Nutrition Society·Albert Flynn
Sep 24, 2011·The Proceedings of the Nutrition Society·David P Richardson
Apr 23, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Marco MiroddiGioacchino Calapai
Jul 19, 2016·British Journal of Pharmacology·Pietro GhezziHarald H H W Schmidt
Mar 10, 2017·International Journal of Food Sciences and Nutrition·Alie de BoerAalt Bast
Oct 20, 2018·Journal of Food Science·Cristina González-DíazCarlos Álvarez-Dardet
Nov 15, 2018·Nutrients·Subhadeep ChakrabartiKaustav Majumder
Oct 5, 2010·Nutrition Reviews·François MariottiIrène Margaritis
Apr 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Molly M ShoresAlvin M Matsumoto
Mar 24, 2012·Public Health Nutrition·Kristy L HawleyKelly D Brownell
Aug 14, 2012·European Journal of Nutrition·S BattaultJ M Maixent
Apr 4, 2014·The American Journal of Clinical Nutrition·J Bruce German
Mar 28, 2017·Pharmaceutical Research·Inas El BialyM Reza Nejadnik
May 30, 2020·Journal of Exposure Science & Environmental Epidemiology·Elaine A Cohen HubalEmma Lavoie
Feb 1, 2012·International Journal of Food Sciences and Nutrition·Dario Gregori, Claudia Elena Gafare
Jul 31, 2020·Nutrition Reviews·Rebecca MathewsYiFang Chu
Aug 13, 2021·HRB Open Research·Susanna DoddPaula R Williamson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.